We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

12 hedge funds and large institutions have $1.47M invested in Tenax Therapeutics in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

41% more capital invested

Capital invested by funds: $1.04M → $1.47M (+$431K)

9% more funds holding

Funds holding: 11 → 12 (+1)

0% more ownership

Funds ownership: 0% → 0% (+0%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $24K

Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
$24K
Net Calls
-$24K
Net Calls Change
-$11K

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$258K
2
Renaissance Technologies
Renaissance Technologies
New York
+$40.8K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$231K
2
VF
Virtu Financial
New York
-$27.2K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$13.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
FWP
1
FAS Wealth Partners
Kansas
$633K – – –
AFM
2
Anson Funds Management
Texas
$297K +$258K +19 New
BBA
3
Baker Bros. Advisors
New York
$171K – – –
Millennium Management
4
Millennium Management
New York
$80K – – –
Bank of New York Mellon
5
Bank of New York Mellon
New York
$67K – – –
Renaissance Technologies
6
Renaissance Technologies
New York
$51K +$40.8K +3 New
Citadel Advisors
7
Citadel Advisors
Florida
$43K – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$36K -$13.6K -1 -33%
Northern Trust
9
Northern Trust
Illinois
$25K – – –
Verition Fund Management
10
Verition Fund Management
Connecticut
$16K – – –
VF
11
Virtu Financial
New York
$11K -$27.2K -2 -67%
TSS
12
Two Sigma Securities
New York
$11K – – –
BlackRock
13
BlackRock
New York
$7K – – –
CCB
14
Cutter & Co Brokerage
Missouri
$7K – – –
Vanguard Group
15
Vanguard Group
Pennsylvania
$6K -$231K -17 Closed
CCMINC
16
Cardinal Capital Management Inc (North Carolina)
North Carolina
$5K – – –
UBS Group
17
UBS Group
Switzerland
$3K – – –
AG
18
Advisor Group
Arizona
$1K – – –
Morgan Stanley
19
Morgan Stanley
New York
$1K – – –

TENX Hedge Fund Activity: Q4 2017 in Review

12 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q4 2017, worth a combined $1.47M — up 41% from $1.04M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new TENX positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $258K. The largest seller was Vanguard Group, exiting entirely with an estimated $231K sold.

  • 12 institutional investors held Tenax Therapeutics (TENX) as of Q4 2017, up from 11 in Q3 2017.
  • Funds reported $1.47M of Tenax Therapeutics stock for Q4 2017, up 41% quarter-over-quarter.
  • 2 funds opened new Tenax Therapeutics positions in Q4 2017 and 1 closed out, a net change of +1 holder.
  • The largest Tenax Therapeutics buyer in Q4 2017 was Anson Funds Management, an estimated $258K added.
  • The largest Tenax Therapeutics seller in Q4 2017 was Vanguard Group, an estimated $231K sold.

Based on aggregated 13F filings for Q4 2017.